CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Planned sale Chief Legal Officer sold 5,760 shares at an average $19.95 ($114,934)
- 4 Open-market sale Chief Legal Officer sold 3,220 shares at an average $19.85 ($63,929)
- 4 Open-market sale Chief Scientific Officer sold 3,690 shares at an average $19.85 ($73,260)
- 4 Open-market sale Chief Financial Officer sold 2,811 shares at an average $19.85 ($55,809)
- 4 Planned sale Chief Legal Officer sold 5,760 shares at $19.50 ($112,295)
- 4 Planned sale Chief Legal Officer sold 5,760 shares at $21.73 ($125,155)
- 4 Planned sale Chief Legal Officer sold 3,290 shares at $25.00 ($82,250)
- 4 Planned sale Chief Legal Officer sold 5,760 shares at $24.28 ($139,867)
- 4 Planned sale Chief Financial Officer sold 3,546 shares at $24.28 ($86,083)
- 4 Open-market sale Chief Financial Officer sold 2,368 shares at $24.31 ($57,554)
- 4 Open-market sale Chief Scientific Officer sold 3,437 shares at $24.31 ($83,536)
- 4 Open-market sale Chief Legal Officer sold 4,182 shares at $24.31 ($101,644)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer sold 3,290 shares at $25.00 ($82,250)
- 4 Planned sale Chief Legal Officer sold 5,760 shares at an average $22.23 ($128,017)
- 4 Planned sale Chief Legal Officer sold 9,050 shares at an average $24.94 ($225,736)
- 4 Planned sale Chief Legal Officer sold 9,870 shares at $25.01 ($246,843)
- 4 Planned sale Chief Financial Officer sold 20,000 shares at $25.22 ($504,370)
- 4 Planned sale Chief Financial Officer sold 3,477 shares at an average $21.45 ($74,576)
Page 5 of 14 · 274 filings